The Claim
Twelve weeks of co-supplementation with 1000 mg omega-3 fatty acids and 400 IU vitamin E significantly improves the total cholesterol to HDL cholesterol ratio by 0.5 units in women with polycystic ovary syndrome.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with polycystic ovary syndrome, taking 1000 mg of omega-3 fatty acids and 400 IU of vitamin E daily for 12 weeks lowers the ratio of total cholesterol to HDL cholesterol by 0.5 units.
See the scientific wording
Twelve weeks of co-supplementation with 1000 mg omega-3 fatty acids and 400 IU vitamin E significantly improves the total cholesterol to HDL cholesterol ratio by 0.5 units in women with polycystic ovary syndrome, indicating a favorable shift in cardiovascular risk profile.
Omega-3 fatty acids and vitamin E work together to calm down harmful chemical reactions in the body that damage fats in the blood. This reduces the production of bad cholesterol particles and helps the liver clear them faster, while also increasing the good cholesterol, which improves the overall balance of cholesterol in the blood.
What the research says
1 studyThis study found that women with PCOS who took omega-3 and vitamin E supplements for 12 weeks had a better balance of 'bad' and 'good' cholesterol, which means their heart disease risk went down. The numbers match exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.